Date | Time | Source | Announcement |
---|---|---|---|
01 Apr 2014 | 05:57 PM | Holding(s) in Company | |
31 Mar 2014 | 02:48 PM | Total Voting Rights | |
31 Mar 2014 | 02:41 PM | Holding(s) in Company | |
27 Mar 2014 | 04:44 PM | Director/PDMR Shareholding | |
20 Mar 2014 | 04:39 PM | Holding(s) in Company | |
19 Mar 2014 | 08:00 AM | Additional Listing | |
18 Mar 2014 | 04:53 PM | Holding(s) in Company | |
18 Mar 2014 | 04:46 PM | Holding(s) in Company | |
18 Mar 2014 | 04:37 PM | Director/PDMR Shareholding | |
18 Mar 2014 | 01:35 PM | Holding(s) in Company | |
18 Mar 2014 | 08:00 AM | Admission to trading on the London Stock Exchange | |
14 Mar 2014 | 06:06 PM | Holding(s) in Company | |
13 Mar 2014 | 05:17 PM | Publication of Prospectus | |
13 Mar 2014 | 07:01 AM | Stabilisation Notice | |
13 Mar 2014 | 07:00 AM | Offer Price Set at 310 Pence per Ordinary Share |
v
NIOX Group PLC is a company focussed on treating people suffering from respiratory diseases through its Nitric Oxide range of inhaler devices which help diagnose and manage asthma. The company is a provider of point-of-care inhaler measurement and monitoring. It is listed on the London Stock Exchange under the ticker NIOX.
NIOX share price launched at 310p in 2014.